Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behavior

Behavioural Brain Research

Volumn 239, Issue 1, 2013, Pages 90-93

  Anderson, Maria E ^a   Runesson, Johan ^b   Saar, Indrek ^c   Langel, Ülo ^b,c   Robinson, John K ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Fixed ratio; Motivation; Neuropeptide; Reward

Indexed keywords

GALANIN DERIVATIVE; GALANIN RECEPTOR 1; GALANIN RECEPTOR 1 AGONIST; GALANIN RECEPTOR 2; GALANIN RECEPTOR 2 AGONIST; SACCHARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL RAT; EXPERIMENTAL STUDY; FIXED RATIO SCHEDULE; FOOD INTAKE; MALE; METHODOLOGY; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REINFORCEMENT; REWARD;

ANIMALS; APPETITIVE BEHAVIOR; BRADYKININ; CONDITIONING, OPERANT; GALANIN; INJECTIONS, INTRAVENTRICULAR; MALE; MOTIVATION; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, GALANIN, TYPE 1; RECEPTOR, GALANIN, TYPE 2; REINFORCEMENT SCHEDULE;

EID: 84869870977     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.10.045     Document Type: Article

References (24)

1. 2+ concentration. Biochemical and Biophysical Research Communications 1986, 140:1059-1063.
2. Ash B.L., Djouma E. Galanin receptors as pharmacological targets in the treatment of addiction. Journal of Addiction Research & Therapy 2011, S4:003.
3. Bek T., Ottesen B., Fahrenkrug J. The effect of galanin, CGRP, and ANP on spontaneous smooth muscle activity of rat uterus. Peptides 1988, 9:497-500.
4. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Research Reviews 1998, 28:309-369.
5. Berridge K.C., Robinson T.E. Parsing reward. Trends in Neurosciences 2003, 26:507-513.
6. Brewer A., Robinson J.K. Galanin stimulation of feeding is blocked by the addition of a response requirement. Behavioral Neuroscience 2008, 122:949-953.
7. Correa M., Carlson B.B., Wisniecki A., Salamone J.D. Nucleus accumbens dopamine and work requirements on interval schedules. Behavioral Brain Research 2002, 137:179-187.
8. Crawley J.N. The role of galanin in feeding behavior. Neuropeptides 1999, 33:369-375.
9. Ericson E., Ahlenius S. Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Research 1999, 822:200-209.
10. Fang P., Yu M., Guo L., Bo P., Zhang Z., Shi M. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides 2012, 36:331-339.
11. Holmes A., Picciotto M.R. Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction?. CNS and Neurological Disorders - Drug Targets 2006, 5:225-232.
12. Krasnow S.M., Hohmann J.G., Gragerov A., Clifton D.K., Steiner R.A. Analysis of the contribution of galanin receptors 1 and 2 to the central actions of galanin-like peptide. Neuroendocrinology 2004, 79:268-277.
13. Lundström L., Sollenberg U., Brewer A., Kouya P.F., Zheng K., Xu X.J., et al. A galanin receptor subtype 1 specific agonist. International Journal of Peptide Research and Therapeutics 2005, 11:17-27.
14. McNamara I.M., Robinson J.K. Conditional stimulation by galanin of saccharin and ethanol consumption under free and response contingent access. Neuropeptides 2010, 44:445-451.
15. Picciotto M.R. Galanin and addiction. Cellular and Molecular Life Sciences 2008, 65:1872-1879.
16. Saar I., Runesson J., McNamara I.M., Järv J., Robinson J.K., Langel ü. Neurochemistry International 2011, 58:714-720.
17. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neuroscience and Biobehavioral Reviews 1997, 21:341-359.
18. Salamone J.D., Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behavioural Brain Research 2002, 137:3-25.
19. Salamone J.D., Correa M., Mingote S.M., Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Current Opinion in Pharmacology 2005, 5:34-41.
20. Salamone J.D. Functions of mesolimbic dopamine: changing concepts and shifting paradigms. Psychopharmacology 2007, 191:461-482.
21. Sollenberg U.E., Runesson J., Sillard R., Langel ü. Binding of chimeric peptides M617 and M871 to galanin receptor type 3 reveals characteristics of galanin receptor-ligand interaction. International Journal of Peptide Research and Therapeutics 2012, 16:17-22.
22. Skofitsch G., Sills M.A., Jacobowitz D.M. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 1986, 7:1029-1042.
23. Weiss J.M., Bonsall R.W., Demetrikopoulos M.K., Emery M.S., West C.H. Galanin: a significant role in depression?. Annals of the New York Academy of Sciences 1998, 863:364-382.
24. Zorrilla E.P., Brennan M., Sabino V., Lu X., Bartfai T. Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge. Physiology and Behavior 2007, 91:479-485.